MindWalk Holdings Corp. (HYFT) vs Verrica Pharmaceuticals Inc. (VRCA)

A side-by-side comparison of MindWalk Holdings Corp. and Verrica Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — HYFT vs VRCA

growth of $100 · dividends reinvested · last 8y
HYFT -67.7% (-13.2%/yr)VRCA -97.5% (-37.1%/yr)HYFT compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $1002020202220242026$32$2
HYFT VRCA

HYFT vs VRCA: by the numbers

  • •HYFT is the larger company ($73M vs $72M market cap).
  • •Both run net losses; VRCA's is the smaller (-102.84% vs -105.29% net margin).
  • •VRCA grew revenue faster over the past five years (20.37% vs -4.48% CAGR).

Metrics side by side

Valuation

MetricHYFTVRCA
P/S ratio6.212.39
P/B ratio14.7816.79

Profitability

MetricHYFTVRCA
Gross margin60.78%85.89%
Operating margin-96.01%-33.56%
Net margin-105.29%-102.84%
ROE-250.39%-724.01%
ROIC-153.46%-207.23%

Growth (annualized)

MetricHYFTVRCA
Revenue CAGR (5Y)-4.48%20.37%
Total return CAGR (5Y)-23.93%-48.68%

Frequently asked

Which has grown faster, HYFT or VRCA?
Over the past five years, VRCA grew revenue faster — HYFT at a -4.48% CAGR versus VRCA at 20.37%.
How have HYFT and VRCA total returns compared?
Over the past 5 years, HYFT delivered -23.93% and VRCA delivered -48.68% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.